-

ProAssurance Corporation Files Supplement to Proxy Statement for Annual Meeting

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) has filed a supplement with the Securities and Exchange Commission to its previously filed proxy statement for ProAssurance’s annual meeting of shareholders that will be held at 10:00 a.m. ET on May 25, 2021.

The proxy statement supplement informs shareholders of a typographical error related to the disclosure of Kevin M. Shook’s compensation in 2020. The Summary Compensation Table on page 37 of the Proxy Statement erroneously showed that Mr. Shook received $384,562 in 2020 compensation pursuant to the Non-Equity Incentive Plan. The correct number is $348,562. Accordingly, the Summary Compensation Table on page 37 of the Proxy Statement should read that, in 2020, Mr. Shook earned $348,562 in compensation pursuant to the Non-Equity Incentive Plan and $1,216,608 in total compensation.

In addition, the supplement revises the disclosure under the heading “Meetings and Committees of the Board of Directors” on page 14 of the Proxy Statement to report that each of the Company’s incumbent directors attended all of the meetings of the committees of the board on which he or she served during 2020. The Proxy Statement erroneously stated that the Company’s incumbent directors attended at least two thirds of all of the meetings of the committees of the board on which he or she served during 2020.

Except as specifically revised by the information contained herein, the supplement does not modify, amend or otherwise affect any of the other information set forth in the Proxy Statement. The proxy statement supplement may be accessed and copies of the supplement may be obtained without charge in the manner described in ProAssurance’s proxy statement and is also available without charge on the SEC’s website at www.sec.gov. Shareholders may also contact Jeff Lisenby, Executive Vice President and Corporate Secretary of ProAssurance at (800) 282-6242, Ext.362668 for assistance in obtaining the proxy statement and the supplement thereto.

About ProAssurance

ProAssurance Corporation is an industry-leading specialty insurer with extensive expertise in healthcare professional liability, products liability for medical technology and life sciences, legal professional liability, and workers’ compensation insurance. ProAssurance Group is rated “A” (Excellent) by AM Best; ProAssurance and its operating subsidiaries are rated “A-” (Strong) by Fitch Ratings. For the latest on ProAssurance and its industry-leading suite of products and services, cutting-edge risk management and practice enhancement programs, follow @ProAssurance on Twitter or LinkedIn. ProAssurance’s YouTube channel regularly presents thought provoking, insightful videos that communicate effective practice management, patient safety and risk management strategies.

Contacts

Ken McEwen
Manager, Investor Relations
800-282-6242 • 205-439-7903 • KenMcEwen@ProAssurance.com

ProAssurance Corporation

NYSE:PRA
Details
Headquarters: Birmingham, AL
CEO: Ned Rand
Employees: 991
Organization: PUB
Revenues: $1,137 million (2023)

Release Summary
ProAssurance Corporation Files Supplement to Proxy Statement for Annual Meeting
Release Versions

Contacts

Ken McEwen
Manager, Investor Relations
800-282-6242 • 205-439-7903 • KenMcEwen@ProAssurance.com

More News From ProAssurance Corporation

ProAssurance Reports Results for Third Quarter 2025

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $1.4 million, or $0.03 per diluted share, and operating income(1) of $7.9 million, or $0.15 per diluted share, for the three months ended September 30, 2025. For the nine months ended September 30, 2025, net income was $17.5 million, or $0.34 per diluted share, and operating income was $41.5 millio...

ProAssurance Reports Results for Second Quarter 2025

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $21.9 million, or $0.42 per diluted share, and operating income(1) of $26.8 million, or $0.52 per diluted share, for the three months ended June 30, 2025. For the six months ended June 30, 2025, net income was $16.1 million, or $0.31 per diluted share, and operating income was $33.6 million, or $0....

The Doctors Company and ProAssurance Announce Early Termination of the Hart-Scott-Rodino Waiting Period

NAPA, Calif. & BIRMINGHAM, Ala.--(BUSINESS WIRE)--The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers’ compensation insurance, announced today that on July 2, 2025, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Sc...
Back to Newsroom